D119N (p.Asp119Asn) variant of KRAS (GTPase KRas)

D119N (p.Asp119Asn) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of Autoimmune lymphoproliferative syndrome type 4; Acute myeloid leukemia; Noonan s. The available variant effect predictions contribute to a CATVariant prioritization score of 0.86 / 1. The record also includes experimental measurements, published literature, and structural context.

D119N (p.Asp119Asn) variant details